Hydrochlorothiazide is a thiazide-type diuretic that is widely prescribed to help control high blood pressure and reduce fluid retention. This article covers Hydrochlorothiazide, available as a generic medication and marketed under brand names such as Microzide, Esidrix, and Hydrodiuril. In Hong Kong, it is classified as a prescription (Rx) drug and is regulated by the Hong Kong Department of Health.
Hydrochlorothiazide acts on the distal convoluted tubule of the kidneys. By inhibiting the sodium-chloride symporter, it reduces the reabsorption of sodium and chloride. The resulting loss of sodium draws water into the urine, increasing urine output. This diuretic effect lowers blood volume, which helps decrease cardiac output and peripheral resistance, ultimately reducing blood pressure. The drug also promotes the excretion of calcium, which can be beneficial for patients at risk of kidney stones.
Hydrochlorothiazide is approved in Hong Kong for the following indications:
It is typically used as part of a broader antihypertensive regimen, often combined with other agents such as ACE inhibitors or calcium-channel blockers.
Ideal candidates are adults who require modest blood-pressure reduction or fluid removal and who have no contraindicating conditions.
Absolute contraindications
Relative contraindications
Special populations
Patients should inform their healthcare provider of all prescription medicines, over-the-counter drugs, supplements, and herbal products before starting Hydrochlorothiazide.
This article provides educational information about Hydrochlorothiazide and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
The two strengths contain the same active ingredient but provide different amounts of the drug. A 12.5 mg tablet is often used to start therapy or in patients who are sensitive to diuretics, while a 25 mg tablet is used when a stronger blood-pressure-lowering effect is needed. The tablet size and appearance may differ depending on the manufacturer.
Many clinicians prescribe potassium chloride or a potassium-rich diet alongside Hydrochlorothiazide to offset the risk of hypokalemia. However, the decision should be individualized, and the combination should be monitored with regular electrolyte testing.
Hydrochlorothiazide is not a prohibited substance in most sporting regulations, but it may be flagged as a diuretic, which can be a masking agent. Athletes should disclose its use to the relevant anti-doping authority and provide a therapeutic use exemption if required.
Most patients experience a modest reduction in systolic and diastolic pressure within 2 - 4 weeks of consistent daily dosing, though peak effects may continue to improve up to 2 months.
Hydrochlorothiazide actually reduces calcium excretion in the urine, which can lower the risk of calcium-oxalate kidney stones. Some clinicians prescribe it specifically for patients with recurrent calcium stones.
The tablets are formulated for whole-pill ingestion. Crushing or splitting may affect the drug’s release profile and should be avoided unless a healthcare professional advises otherwise.
Severe cramps may signal low potassium. Contact a healthcare provider promptly for electrolyte testing and possible adjustment of the dose or addition of a potassium supplement.
Most nonsedating antihistamines have minimal interaction with Hydrochlorothiazide. However, some first-generation antihistamines can cause additional drowsiness or dry mouth, which may be compounded by diuretic-induced dehydration.
When traveling, stay well-hydrated but avoid excessive fluid intake that can offset the diuretic effect. Keep the medication in its original labeled container and carry a copy of the prescription for customs or airport security checks.
Both are thiazide-type agents, but chlorthalidone has a longer half-life and may provide more sustained blood-pressure control. Some guidelines suggest chlorthalidone as a first-line option for certain patients, while Hydrochlorothiazide remains widely used due to its established safety profile and lower cost.
